Suspension - ChuanYin High-Tech: China Seed Group intends to acquire 298 million shares, stock to resume trading [1] - HuiBoPu: Water Industry Group plans to transfer 25%-30% of company shares, stock suspended [1] - TianSheng New Materials: Major shareholder Wu Haizhou is planning significant matters that may lead to a change in control, stock suspended [2] Private Placement and Mergers - RiJiu Optoelectronics: Plans to raise no more than 800 million yuan for a project to produce 6 million square meters of functional films and to supplement working capital [3] - QuanXin Co., Ltd.: Plans to issue convertible bonds to raise no more than 1.2 billion yuan for the production of integrated products for commercial aviation transmission and communication [3] - BeiFang ChangLong: Plans to acquire 51% of Shunyi Technology, expected to constitute a major asset restructuring [3] Share Buybacks - XingChen Technology: Plans to repurchase shares for 60 million to 120 million yuan, with a maximum repurchase price of 88.90 yuan per share [4] - XinKaiYuan: Plans to repurchase shares for 40 million to 50 million yuan, with a maximum repurchase price of 25.77 yuan per share [4] External Investments and Daily Operations - RunJian Co., Ltd.: Signed a strategic cooperation framework agreement with JD Technology to expand cooperation in AI applications and intelligent computing cloud [4] - YueDianLi A: The expansion project of Huizhou Power Plant Units 5 and 6 (2×1000MW) has a total investment of 8.05 billion yuan, with Unit 5 now in operation [5] - ZhongWu Drone: Signed a contract for drone systems worth over 100 million yuan, expected to positively impact annual operating performance [6] - TianNeng Co., Ltd.: Plans to use no more than 12 billion yuan of self-owned funds for entrusted wealth management [7] - ChangHong Technology: Its subsidiary has secured over half of the procurement share from a major domestic wafer factory for semiconductor consumables by 2026 [7] - AiMeiKe: Exclusive distributor of injectable type A botulinum toxin products has obtained drug registration certificate [7] - KangTai Biology: Clinical trial application for acellular pertussis-diphtheria-tetanus combined vaccine has been accepted [8] - PaiRui Co., Ltd.: Signed a framework agreement for bulk procurement of IGBT chips, with total supply amounting to approximately 1.3 to 1.4 billion yuan for 2028, 2029, and 2030 [8] Performance Changes - JinLi YongCi: Expected net profit of 660 million to 760 million yuan in 2025, a year-on-year increase of 127%-161% due to small batch deliveries of robotic motor rotors and magnetic materials [9] - YingQu Technology: Expected net profit of 540 million to 660 million yuan in 2025, a year-on-year increase of 114.69%-162.40%, with significant fair value changes from equity investments expected to add 381 million yuan to net profit [9] - AiBiSen: Expected net profit of 240 million to 290 million yuan in 2025, a year-on-year increase of 105.32%-148.09% [9] - WenShi Co., Ltd.: Expected net profit in 2025 to decrease by 40.73%-46.12% year-on-year due to declining profits in pig and chicken farming [9]
1月8日晚间公告 | 润建股份与京东科技围绕AI应用、智算等签订战略合作;派瑞股份签订IGBT芯片批量采购框架协议